Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

HSR-609: a potent and insurmountable H1 antagonist in vitro

March 26, 1998

No Comments

Hoechst discovers inhibitors of various inflammatory mediators

March 25, 1998

No Comments

CytoMed and UCB join forces to develop antiinflammatory therapeutics

March 25, 1998

No Comments

PathoGenesis seeks Canadian approval for TOBI in CF

March 25, 1998

No Comments

New antiasthmatic agents claimed by Byk Gulden

March 25, 1998

No Comments

Epi-2010, a novel antisense oligonucleotide for asthma

March 24, 1998

No Comments

Jak-2 inhibitor indicated for control of allergic inflammation

March 24, 1998

No Comments

Clinical efficacy demonstrated for rhuMAb-E25 in asthma

March 24, 1998

No Comments

PPL's AAT granted orphan drug status by FDA

March 24, 1998

No Comments

Preliminary clinical efficacy demonstrated for PDE III inhibitor in asthma

March 24, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Respiratory
RSS

HSR-609: a potent and insurmountable H1 antagonist in vitro

Hoechst discovers inhibitors of various inflammatory mediators

CytoMed and UCB join forces to develop antiinflammatory therapeutics

PathoGenesis seeks Canadian approval for TOBI in CF

New antiasthmatic agents claimed by Byk Gulden

Epi-2010, a novel antisense oligonucleotide for asthma

Jak-2 inhibitor indicated for control of allergic inflammation

Clinical efficacy demonstrated for rhuMAb-E25 in asthma

PPL's AAT granted orphan drug status by FDA

Preliminary clinical efficacy demonstrated for PDE III inhibitor in asthma

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Respiratory RSS

Respiratory
RSS